AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial

AstraZeneca said on Tuesday a late-stage trial failed to provide evidence that its COVID-19 antibody therapy protected people who had contact with an infected person from the disease, a small setback in its efforts to find alternatives to vaccines.

from bdnews24.com - Home https://ift.tt/3q0ZGmb